Payne SG et al. |
The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. |
2007 |
Blood |
pmid:17008548
|
Reddy RC et al. |
Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. |
2008 |
Blood |
pmid:18535203
|
Appel S et al. |
PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. |
2005 |
Blood |
pmid:16105976
|
Piliponsky AM et al. |
Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. |
2003 |
Blood |
pmid:12393403
|
Wang LH et al. |
Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. |
2007 |
Blood |
pmid:17785586
|
Monneret G et al. |
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. |
2001 |
Blood |
pmid:11535533
|
Chaffer CL et al. |
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. |
2006 |
BMC Cancer |
pmid:16519808
|
Jeong KT et al. |
Anti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis. |
2014 |
BMC Complement Altern Med |
pmid:24521096
|
Le Loupp AG et al. |
Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system. |
2015 |
BMC Gastroenterol |
pmid:26338799
|
Nakahata Y et al. |
The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks. |
2006 |
BMC Mol. Biol. |
pmid:16483373
|
Garg TK and Chang JY |
Oxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2. |
2003 |
BMC Ophthalmol |
pmid:12659653
|
Garg TK and Chang JY |
15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress. |
2004 |
BMC Pharmacol. |
pmid:15149553
|
Seckl J |
Mechanisms of fetal origins of health problems in adults need to be investigated. |
1998 |
BMJ |
pmid:9665923
|
Yue L et al. |
Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways. |
2014 |
Bone |
pmid:24345643
|
Lin TH et al. |
PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. |
2007 |
Bone |
pmid:17669705
|
Hounoki H et al. |
Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. |
2008 |
Bone |
pmid:18242157
|
Yue L et al. |
Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway. |
2012 |
Bone |
pmid:22705147
|
Stellato C et al. |
General anaesthetics induce only histamine release selectively from human mast cells. |
1991 |
Br J Anaesth |
pmid:1722691
|
Barr RM et al. |
The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin. |
1988 |
Br J Clin Pharmacol |
pmid:2835975
|
Johnston SL et al. |
The effects of an oral thromboxane TP receptor antagonist BAY u 3405, on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations. |
1992 |
Br J Clin Pharmacol |
pmid:1467134
|
Scadding GK et al. |
Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge. |
1994 |
Br J Clin Pharmacol |
pmid:7893587
|
al Jarad N et al. |
Effects of a thromboxane receptor antagonist on prostaglandin D2 and histamine induced bronchoconstriction in man. |
1994 |
Br J Clin Pharmacol |
pmid:8148229
|
Wood-Baker R et al. |
The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects. |
1995 |
Br J Clin Pharmacol |
pmid:7742148
|
Rees MC and Kelly RW |
Prostaglandin D2 release by endometrium and myometrium. |
1986 |
Br J Obstet Gynaecol |
pmid:3466645
|
Matsuo T and Cynader MS |
The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle. |
1993 |
Br J Ophthalmol |
pmid:8435410
|
Goh Y et al. |
Prostaglandin D2 reduces intraocular pressure. |
1988 |
Br J Ophthalmol |
pmid:3164634
|
Nishida K et al. |
Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma. |
2002 |
Br. J. Cancer |
pmid:11953889
|
Chearwae W and Bright JJ |
PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. |
2008 |
Br. J. Cancer |
pmid:19018263
|
Siavash H et al. |
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells. |
2004 |
Br. J. Cancer |
pmid:15316561
|
Nikitakis NG et al. |
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. |
2002 |
Br. J. Cancer |
pmid:12454768
|
Heilmann S et al. |
No genetic support for a contribution of prostaglandins to the aetiology of androgenetic alopecia. |
2013 |
Br. J. Dermatol. |
pmid:23448296
|
Massey WA et al. |
Profile of prostanoid release following antigen challenge in vivo in the skin of man. |
1991 |
Br. J. Dermatol. |
pmid:1760357
|
Koro O et al. |
Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. |
1986 |
Br. J. Dermatol. |
pmid:2432916
|
Hensby CN et al. |
Prostaglandins in human skin disease. |
1983 |
Br. J. Dermatol. |
pmid:6574787
|
Neely SM et al. |
Mechanism and characteristics of platelet activation by haematin. |
1984 |
Br. J. Haematol. |
pmid:6383458
|
Pacienza N et al. |
15-deoxy-Delta(12,14)-PGJ(2) induces cell cycle arrest and apoptosis of haematopoietic progenitors. |
2010 |
Br. J. Haematol. |
pmid:19764987
|
Pan IQ et al. |
Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. |
1984 |
Br. J. Haematol. |
pmid:6089860
|
Aukema HM et al. |
Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. |
2013 |
Br. J. Nutr. |
pmid:23151363
|
Giles H et al. |
A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2. |
1991 |
Br. J. Pharmacol. |
pmid:1665742
|
Ward JE et al. |
PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms. |
2004 |
Br. J. Pharmacol. |
pmid:14718259
|
Kiriyama M et al. |
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. |
1997 |
Br. J. Pharmacol. |
pmid:9313928
|
Hamid S and Whittle BJ |
Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets. |
1985 |
Br. J. Pharmacol. |
pmid:2992652
|
Narumiya S and Toda N |
Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues. |
1985 |
Br. J. Pharmacol. |
pmid:2992661
|
Fernando MR et al. |
Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells. |
2016 |
Br. J. Pharmacol. |
pmid:26676587
|
Guan NN et al. |
Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2. |
2015 |
Br. J. Pharmacol. |
pmid:25917171
|
Hamid-Bloomfield S and Whittle BJ |
Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets. |
1986 |
Br. J. Pharmacol. |
pmid:3017497
|
Schmidt JA et al. |
Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma. |
2013 |
Br. J. Pharmacol. |
pmid:23146091
|
Minami T et al. |
Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice. |
1997 |
Br. J. Pharmacol. |
pmid:9113374
|
Roviezzo F et al. |
S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms. |
2015 |
Br. J. Pharmacol. |
pmid:25439580
|
Teixeira MM et al. |
Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils. |
1997 |
Br. J. Pharmacol. |
pmid:9146890
|
Hamid-Bloomfield S and Whittle BJ |
Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C. |
1989 |
Br. J. Pharmacol. |
pmid:2647205
|
Du H et al. |
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ. |
2011 |
Br. J. Pharmacol. |
pmid:21501147
|
Molderings G et al. |
Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype. |
1992 |
Br. J. Pharmacol. |
pmid:1330175
|
Bardelli C et al. |
Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands. |
2012 |
Br. J. Pharmacol. |
pmid:21745193
|
Sharif NA et al. |
Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand. |
2000 |
Br. J. Pharmacol. |
pmid:11082108
|
Mesquita-Santos FP et al. |
Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils. |
2011 |
Br. J. Pharmacol. |
pmid:20973774
|
Wasinger C et al. |
Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. |
2014 |
Br. J. Pharmacol. |
pmid:25091578
|
Alves C et al. |
Effects of 15d-PGJâ‚‚-loaded poly(D,L-lactide-co-glycolide) nanocapsules on inflammation. |
2011 |
Br. J. Pharmacol. |
pmid:20883476
|
Church MK and Hiroi J |
Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. |
1987 |
Br. J. Pharmacol. |
pmid:2435353
|
Wright DH et al. |
Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist. |
1998 |
Br. J. Pharmacol. |
pmid:9579725
|
Davis TL and Sharif NA |
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. |
2000 |
Br. J. Pharmacol. |
pmid:10952683
|
Woodward DF et al. |
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds. |
2000 |
Br. J. Pharmacol. |
pmid:10952685
|
Davidson J et al. |
Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up-regulation of 15-deoxyΔ(12,14) prostaglandin J2 production. |
2013 |
Br. J. Pharmacol. |
pmid:23586396
|
Minami T et al. |
Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. |
1997 |
Br. J. Pharmacol. |
pmid:9375954
|
Finney MJ et al. |
Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. |
1985 |
Br. J. Pharmacol. |
pmid:2411319
|
Gaspar Elsas MI et al. |
Murine myeloid progenitor responses to GM-CSF and eosinophil precursor responses to IL-5 represent distinct targets for downmodulation by prostaglandin E(2). |
2000 |
Br. J. Pharmacol. |
pmid:10903977
|
Trist DG et al. |
The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase. |
1989 |
Br. J. Pharmacol. |
pmid:2466517
|
Barr RM et al. |
The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. |
1988 |
Br. J. Pharmacol. |
pmid:2460180
|
Wilson RJ et al. |
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist. |
2006 |
Br. J. Pharmacol. |
pmid:16604093
|
Chan CL et al. |
Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. |
2000 |
Br. J. Pharmacol. |
pmid:10711359
|
Benyon RC et al. |
Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. |
1989 |
Br. J. Pharmacol. |
pmid:2474353
|
Benyon RC et al. |
Prostaglandin D2 release from human skin mast cells in response to ionophore A23187. |
1987 |
Br. J. Pharmacol. |
pmid:2447989
|
Armstrong RA et al. |
Competitive antagonism at thromboxane receptors in human platelets. |
1985 |
Br. J. Pharmacol. |
pmid:2580580
|
Shahbazian A et al. |
Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine. |
2002 |
Br. J. Pharmacol. |
pmid:12429577
|
Giles H et al. |
The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. |
1989 |
Br. J. Pharmacol. |
pmid:2924081
|
Keery RJ and Lumley P |
AH6809, a prostaglandin DP-receptor blocking drug on human platelets. |
1988 |
Br. J. Pharmacol. |
pmid:2460179
|
Palea S et al. |
Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. |
1998 |
Br. J. Pharmacol. |
pmid:9692770
|
Rouaud C et al. |
The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation. |
1999 |
Br. J. Pharmacol. |
pmid:10051118
|
Hay DW et al. |
Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. |
1993 |
Br. J. Pharmacol. |
pmid:7507780
|
Walch L et al. |
Prostanoid receptors involved in the relaxation of human pulmonary vessels. |
1999 |
Br. J. Pharmacol. |
pmid:10193765
|
Norel X et al. |
Prostanoid receptors involved in the relaxation of human bronchial preparations. |
1999 |
Br. J. Pharmacol. |
pmid:10193766
|
De Vries GW et al. |
An EP receptor with a novel pharmacological profile in the T-cell line Jurkat. |
1995 |
Br. J. Pharmacol. |
pmid:7582550
|
Cuzzocrea S et al. |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. |
2003 |
Br. J. Pharmacol. |
pmid:12970094
|
Brambilla R et al. |
Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. |
1999 |
Br. J. Pharmacol. |
pmid:10188963
|
Barnes VF and Heavey DJ |
Effect of prostaglandin D2 on histamine-induced weals in human skin. |
1986 |
Br. J. Pharmacol. |
pmid:3456816
|
Holgate ST and Robinson C |
6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. |
1984 |
Br. J. Pharmacol. |
pmid:6439267
|
Crider JY et al. |
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. |
1999 |
Br. J. Pharmacol. |
pmid:10369474
|
Costall B et al. |
Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent. |
1985 |
Br. J. Pharmacol. |
pmid:3862460
|
Hardy CC et al. |
Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man. |
1986 |
Br. J. Pharmacol. |
pmid:3467804
|
Francis HP et al. |
BAY u3405 an antagonist of thromboxane A2- and prostaglandin D2-induced bronchoconstriction in the guinea-pig. |
1991 |
Br. J. Pharmacol. |
pmid:1797323
|
Strakhova MI et al. |
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties. |
2009 |
Br. J. Pharmacol. |
pmid:19413570
|
Hamid-Bloomfield S et al. |
The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C. |
1990 |
Br. J. Pharmacol. |
pmid:2119842
|
Butchers PR et al. |
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. |
1991 |
Br. J. Pharmacol. |
pmid:1724629
|
Ito S et al. |
Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea. |
1990 |
Br. J. Pharmacol. |
pmid:2158830
|
Wright DH et al. |
The human prostanoid DP receptor stimulates mucin secretion in LS174T cells. |
2000 |
Br. J. Pharmacol. |
pmid:11139429
|
Cuzzocrea S et al. |
The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. |
2003 |
Br. J. Pharmacol. |
pmid:12598422
|
MartÃn AR et al. |
The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. |
2006 |
Br. J. Pharmacol. |
pmid:16474422
|
Hao GH et al. |
Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. |
2008 |
Br. J. Pharmacol. |
pmid:18278065
|
Abramovich DR et al. |
The effect of prostaglandin D2 on the blood vessels of the perfused isolated cotyledon of the human placenta. |
1984 |
Br. J. Pharmacol. |
pmid:6584189
|
Sawyer N et al. |
Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. |
2002 |
Br. J. Pharmacol. |
pmid:12466225
|